GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (MIL:DIA) » Definitions » EBITDA Margin %

Diasorin SpA (MIL:DIA) EBITDA Margin % : 19.07% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Diasorin SpA's EBITDA for the three months ended in Dec. 2023 was €58 Mil. Diasorin SpA's Revenue for the three months ended in Dec. 2023 was €302 Mil. Therefore, Diasorin SpA's EBITDA margin for the quarter that ended in Dec. 2023 was 19.07%.


Diasorin SpA EBITDA Margin % Historical Data

The historical data trend for Diasorin SpA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA EBITDA Margin % Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.55 43.77 41.88 37.78 32.09

Diasorin SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.88 20.79 21.16 17.78 19.07

Competitive Comparison of Diasorin SpA's EBITDA Margin %

For the Diagnostics & Research subindustry, Diasorin SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's EBITDA Margin % falls into.



Diasorin SpA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Diasorin SpA's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=368.513/1148.21
=32.09 %

Diasorin SpA's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=57.629/302.21
=19.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diasorin SpA  (MIL:DIA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Diasorin SpA EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA (MIL:DIA) Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.

Diasorin SpA (MIL:DIA) Headlines

From GuruFocus

Harvest Investment Services, LLC Buys 1, Sells 4 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-19-2022

NISSAY ASSET MANAGEMENT CORP /JAPAN/ /ADV Buys 1, Sells 4 in 1st Quarter

By GuruFocus Research GuruFocus Editor 05-19-2022